Literature DB >> 1660674

Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.

H Asakura1, H Jokaji, M Saito, C Uotani, I Kumabashiri, E Morishita, M Yamazaki, T Matsuda.   

Abstract

We examined the changes in plasma levels of soluble thrombomodulin in 66 cases of disseminated intravascular coagulation (DIC), to investigate the damage to vascular endothelial cells and its relationship to multiple organ failure. A significant elevation of plasma levels of soluble thrombomodulin was observed in most cases of DIC, especially in patients with sepsis. However, no such significant elevation was observed in patients with acute promyelocytic leukemia. Plasma levels of both soluble thrombomodulin and active plasminogen activator inhibitor were higher in the cases of DIC with multiple organ failure than in those without multiple organ failure. The levels of soluble thrombomodulin were decreased with the clinical improvement in most cases of DIC but were further increased or remained at high levels in patients who showed no improvement of DIC. It was suggested that an increase in soluble thrombomodulin indicates the damage to the vascular endothelial cells in cases of DIC and that the damage to vascular endothelial cells plays some role in further progression of multiple organ failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660674     DOI: 10.1002/ajh.2830380406

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Identification of functional endothelial protein C receptor in human plasma.

Authors:  S Kurosawa; D J Stearns-Kurosawa; N Hidari; C T Esmon
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

2.  Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity.

Authors:  M W Boehme; U Raeth; P R Galle; W Stremmel; W A Scherbaum
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.

Authors:  T Iba; Y Yagi; A Kidokoro; M Fukunaga; T Fukunaga
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  Thrombomodulin in intensive care patients.

Authors:  J Boldt; T Wollbrück; S Sonneborn; A Welters; G Hempelmann
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

5.  A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model.

Authors:  Jorge G Ganopolsky; Francis J Castellino
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

6.  Increased serum thrombomodulin level is associated with disease severity and mortality in pediatric sepsis.

Authors:  Jainn-Jim Lin; Hsiang-Ju Hsiao; Oi-Wa Chan; Yu Wang; Shao-Hsuan Hsia; Cheng-Hsun Chiu
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

7.  Damage-associated molecular patterns in intensive care unit patients with acute liver injuries: A prospective cohort study.

Authors:  Naoki Hayase; Kent Doi; Takahiro Hiruma; Ryota Inokuchi; Yoshifumi Hamasaki; Eisei Noiri; Masaomi Nangaku; Naoto Morimura
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.